NO20040775L - Oftalmisk sammensetning som innbefatter et askomycin - Google Patents

Oftalmisk sammensetning som innbefatter et askomycin

Info

Publication number: NO20040775L
Authority: NO; Norway
Prior art keywords: ascomycin; composition including; ophthalmic composition; ophthalmic; composition
Prior art date: 2001-08-23

Application number

NO20040775A

Other languages

English (en)

Inventor

Michelle Pik-Han Wong

Kasey Jon Minick

Maggy Babiole Saunier

Jean-Claude Bizec

Andrea Fetz

Christian Schoch

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-23

Filing date

2004-02-17

Publication date

2004-02-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23219986&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20040775(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-02-17 Application filed by Novartis Ag filed Critical Novartis Ag

2004-02-17 Publication of NO20040775L publication Critical patent/NO20040775L/no

Links

ZDQSOHOQTUFQEM-PKUCKEGBSA-N ascomycin Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-PKUCKEGBSA-N 0.000 title 1
ZDQSOHOQTUFQEM-XCXYXIJFSA-N ascomycin Natural products CC[C@H]1C=C(C)C[C@@H](C)C[C@@H](OC)[C@H]2O[C@@](O)([C@@H](C)C[C@H]2OC)C(=O)C(=O)N3CCCC[C@@H]3C(=O)O[C@H]([C@H](C)[C@@H](O)CC1=O)C(=C[C@@H]4CC[C@@H](O)[C@H](C4)OC)C ZDQSOHOQTUFQEM-XCXYXIJFSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)

NO20040775A 2001-08-23 2004-02-17 Oftalmisk sammensetning som innbefatter et askomycin NO20040775L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US31444801P	2001-08-23	2001-08-23
PCT/EP2002/009408 WO2003017990A2 (en)	2001-08-23	2002-08-22	Ophthalmic composition comprising an ascomycin

Publications (1)

Publication Number	Publication Date
NO20040775L true NO20040775L (no)	2004-02-17

Family

ID=23219986

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040775A NO20040775L (no)	2001-08-23	2004-02-17	Oftalmisk sammensetning som innbefatter et askomycin

Country Status (27)

Country	Link
US (2)	US20030050255A1 (no)
EP (1)	EP1420787B8 (no)
JP (1)	JP2005501105A (no)
KR (2)	KR20100089108A (no)
CN (1)	CN100366251C (no)
AR (1)	AR035293A1 (no)
AT (1)	ATE452638T1 (no)
AU (1)	AU2002331172B2 (no)
BR (1)	BR0211972A (no)
CA (1)	CA2457034C (no)
CO (1)	CO5560568A2 (no)
DE (1)	DE60234840D1 (no)
EC (1)	ECSP044981A (no)
ES (1)	ES2337130T3 (no)
HU (1)	HUP0402396A3 (no)
IL (1)	IL160374A0 (no)
MX (1)	MXPA04001646A (no)
MY (1)	MY157377A (no)
NO (1)	NO20040775L (no)
NZ (1)	NZ531224A (no)
PE (1)	PE20030311A1 (no)
PL (1)	PL208685B1 (no)
PT (1)	PT1420787E (no)
RU (1)	RU2313344C2 (no)
TW (1)	TWI324925B (no)
WO (1)	WO2003017990A2 (no)
ZA (1)	ZA200400772B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7354574B2 (en)	2002-11-07	2008-04-08	Advanced Ocular Systems Limited	Treatment of ocular disease
BE1015610A3 (nl) *	2003-07-17	2005-06-07	Corrutech Nv	Verbeterde lijm en werkwijze voor het vervaardigen ervan.
US7083802B2 (en)	2003-07-31	2006-08-01	Advanced Ocular Systems Limited	Treatment of ocular disease
JP2007505932A (ja)	2003-09-18	2007-03-15	マクサイト，インコーポレイテッド	経強膜送達
US7087237B2 (en) *	2003-09-19	2006-08-08	Advanced Ocular Systems Limited	Ocular solutions
US7083803B2 (en)	2003-09-19	2006-08-01	Advanced Ocular Systems Limited	Ocular solutions
WO2006086750A1 (en)	2005-02-09	2006-08-17	Macusight, Inc.	Liquid formulations for treatment of diseases or conditions
PL1904056T3 (pl)	2005-07-18	2009-09-30	Minu Llc	Zastosowanie makrolidu do przywracania czucia rogówkowego
US8492400B2 (en)	2006-02-09	2013-07-23	Santen Pharmaceutical Co., Ltd.	Stable formulations, and methods of their preparation and use
CN101443004B (zh)	2006-03-23	2013-03-06	参天制药株式会社	用于与血管通透性有关的疾病或病症的制剂
CA2691914C (en) *	2007-07-11	2012-06-26	Pfizer Inc.	Pharmaceutical compositions and methods of treating dry eye disorders
US11969501B2 (en)	2008-04-21	2024-04-30	Dompé Farmaceutici S.P.A.	Auris formulations for treating otic diseases and conditions
BRPI0910850B1 (pt)	2008-04-21	2022-06-14	Otonomy, Inc.	Composição intratimpânica compreendendo fator neurotrófico de crescimento derivado do cérebro (bdnf) para o tratamento ou prevenção da perda auditiva
WO2009139924A2 (en)	2008-05-14	2009-11-19	Otonomy, Inc.	Controlled release corticosteroid compositions and methods for the treatment of otic disorders
US8648119B2 (en)	2008-05-23	2014-02-11	Otonomy, Inc.	Controlled release immunomodulator compositions and methods for the treatment of otic disorders
US8846770B2 (en)	2008-06-18	2014-09-30	Otonomy, Inc.	Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
WO2010011466A2 (en)	2008-06-27	2010-01-28	Otonomy, Inc.	Controlled-release cns modulating compositions and methods for the treatment of otic disorders
US8349353B2 (en)	2008-06-27	2013-01-08	Otonomy, Inc.	Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
US8318817B2 (en)	2008-07-21	2012-11-27	Otonomy, Inc.	Controlled release antimicrobial compositions and methods for the treatment of otic disorders
CN102105133B (zh)	2008-07-21	2015-06-17	奥德纳米有限公司	控制释放型耳结构调节和先天性免疫系统调节组合物以及治疗耳部病症的方法
US8399018B2 (en)	2008-07-21	2013-03-19	Otonomy, Inc.	Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
US8496957B2 (en)	2008-07-21	2013-07-30	Otonomy, Inc	Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
AU2009307825A1 (en)	2008-10-22	2010-04-29	Rick FRIEDMAN	Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor
WO2015031393A1 (en)	2013-08-27	2015-03-05	Otonomy, Inc.	Treatment of pediatric otic disorders
EP4374861A3 (en)	2015-11-16	2024-08-07	MedinCell S.A.	A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
WO2018053173A1 (en)	2016-09-16	2018-03-22	Otonomy, Inc.	Otic gel formulations for treating otitis externa
JP7699426B2 (ja) *	2018-11-30	2025-06-27	ロート製薬株式会社	光線による障害からの細胞保護用眼科組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0459148B1 (en) *	1990-05-29	1996-01-03	Ocular Research Of Boston Inc.	Dry eye treatment composition
US5247076A (en) *	1991-09-09	1993-09-21	Merck & Co., Inc.	Imidazolidyl macrolides having immunosuppressive activity
EP0551626A1 (en) *	1991-12-19	1993-07-21	LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d.	Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5302584A (en) *	1992-10-13	1994-04-12	American Home Products Corporation	Carbamates of rapamycin
JPH06345646A (ja) *	1993-06-08	1994-12-20	Fujisawa Pharmaceut Co Ltd	ローション剤
NZ331824A (en) *	1994-10-26	2000-01-28	Novartis Ag	use of an unsaturated fatty alcohol to stabilise a macrolide in a pharmaceutical composition
AR004480A1 (es) *	1995-04-06	1998-12-16	Amico Derin C D	Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
JP4221762B2 (ja) *	1997-04-11	2009-02-12	アステラス製薬株式会社	医薬組成物
CZ287497B6 (cs) *	1997-12-30	2000-12-13	Galena, A. S.	Topické oční přípravky s imunosupresivními látkami
CN1190194C (zh) *	1999-04-30	2005-02-23	苏坎波公司	用于治疗干眼的大环内酯化合物的应用

2002
- 2002-08-21 AR ARP020103137A patent/AR035293A1/es unknown
- 2002-08-21 TW TW091118911A patent/TWI324925B/zh not_active IP Right Cessation
- 2002-08-22 AT AT02767419T patent/ATE452638T1/de active
- 2002-08-22 AU AU2002331172A patent/AU2002331172B2/en not_active Ceased
- 2002-08-22 KR KR1020107014068A patent/KR20100089108A/ko not_active Abandoned
- 2002-08-22 MY MYPI20023102A patent/MY157377A/en unknown
- 2002-08-22 ES ES02767419T patent/ES2337130T3/es not_active Expired - Lifetime
- 2002-08-22 CN CNB028164466A patent/CN100366251C/zh not_active Expired - Fee Related
- 2002-08-22 MX MXPA04001646A patent/MXPA04001646A/es active IP Right Grant
- 2002-08-22 CA CA2457034A patent/CA2457034C/en not_active Expired - Fee Related
- 2002-08-22 HU HU0402396A patent/HUP0402396A3/hu unknown
- 2002-08-22 DE DE60234840T patent/DE60234840D1/de not_active Expired - Lifetime
- 2002-08-22 KR KR10-2004-7002458A patent/KR20040030157A/ko not_active Ceased
- 2002-08-22 PT PT02767419T patent/PT1420787E/pt unknown
- 2002-08-22 WO PCT/EP2002/009408 patent/WO2003017990A2/en not_active Ceased
- 2002-08-22 EP EP02767419A patent/EP1420787B8/en not_active Expired - Lifetime
- 2002-08-22 PE PE2002000808A patent/PE20030311A1/es not_active Application Discontinuation
- 2002-08-22 JP JP2003522510A patent/JP2005501105A/ja active Pending
- 2002-08-22 IL IL16037402A patent/IL160374A0/xx unknown
- 2002-08-22 NZ NZ531224A patent/NZ531224A/en not_active IP Right Cessation
- 2002-08-22 RU RU2004108463/15A patent/RU2313344C2/ru not_active IP Right Cessation
- 2002-08-22 BR BR0211972-2A patent/BR0211972A/pt active Search and Examination
- 2002-08-22 PL PL367459A patent/PL208685B1/pl not_active IP Right Cessation
- 2002-08-23 US US10/227,086 patent/US20030050255A1/en not_active Abandoned
2004
- 2004-01-30 ZA ZA200400772A patent/ZA200400772B/en unknown
- 2004-02-17 NO NO20040775A patent/NO20040775L/no not_active Application Discontinuation
- 2004-02-18 EC EC2004004981A patent/ECSP044981A/es unknown
- 2004-02-18 CO CO04013810A patent/CO5560568A2/es not_active Application Discontinuation
2010
- 2010-11-30 US US12/955,950 patent/US20110071186A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003017990A3 (en)	2003-08-28
ES2337130T3 (es)	2010-04-21
IL160374A0 (en)	2004-07-25
EP1420787B8 (en)	2010-09-01
JP2005501105A (ja)	2005-01-13
RU2313344C2 (ru)	2007-12-27
HUP0402396A2 (hu)	2005-09-28
US20110071186A1 (en)	2011-03-24
PT1420787E (pt)	2010-03-01
CA2457034A1 (en)	2003-03-06
NZ531224A (en)	2005-09-30
PE20030311A1 (es)	2003-05-08
CA2457034C (en)	2010-07-27
WO2003017990A2 (en)	2003-03-06
RU2004108463A (ru)	2005-05-10
HUP0402396A3 (en)	2005-12-28
BR0211972A (pt)	2004-09-21
AR035293A1 (es)	2004-05-05
ZA200400772B (en)	2004-10-11
KR20100089108A (ko)	2010-08-11
CO5560568A2 (es)	2005-09-30
DE60234840D1 (de)	2010-02-04
CN100366251C (zh)	2008-02-06
PL208685B1 (pl)	2011-05-31
KR20040030157A (ko)	2004-04-08
US20030050255A1 (en)	2003-03-13
ECSP044981A (es)	2004-04-28
ATE452638T1 (de)	2010-01-15
AU2002331172B2 (en)	2005-12-01
PL367459A1 (en)	2005-02-21
EP1420787B1 (en)	2009-12-23
MXPA04001646A (es)	2004-05-31
CN1545414A (zh)	2004-11-10
HK1065961A1 (en)	2005-03-11
EP1420787A2 (en)	2004-05-26
TWI324925B (en)	2010-05-21
MY157377A (en)	2016-06-15

Legal Events

Date	Code	Title	Description
2011-04-04	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
CY20162200002T2 (el)	2017-01-25	Αντιιικοι παραγοντες
DE60234840D1 (de)	2010-02-04	Ascomycin enthaltende ophthalmische zubereitungen
DE60200746D1 (de)	2004-08-19	Kautschukzusammensetzung
DE60216493D1 (de)	2007-01-11	Intraokularlinse
NO20034176D0 (no)	2003-09-19	Pyrazolopyrimidiner som terapeutiske midler
NO20034177L (no)	2003-11-21	Pyrazolopyrimidiner som terapeutiske midler
DK1437106T3 (da)	2013-07-08	Prøveimplantatsæt
NO20042955L (no)	2004-07-12	Substituerte fenylaftalener som estrogene midler
NO20035224D0 (no)	2003-11-24	Oftalmisk pirenzepingel
DE10290365T1 (de)	2003-12-18	Gummizusammensetzung
NO20044092L (no)	2004-09-27	Oftalmisk sammensetning som innbefatter ascomycin
DE60212442D1 (de)	2006-07-27	Kautschukzusammensetzung
NO20020319L (no)	2002-01-21	Oftalmisk sammensetning
DE60129749D1 (de)	2007-09-13	Kautschukzusammensetzung
DE60322421D1 (de)	2008-09-04	Verbesserter brillenbügel
ITMO20010248A0 (it)	2001-12-12	Dilatometro ottico perfezionato
DE50307217D1 (de)	2007-06-21	Glaskörper
DK1451433T3 (da)	2006-07-17	Glassammensætning
NO20043664L (no)	2004-09-01	Ny fremgangsmate
FR2832920B1 (fr)	2004-10-01	Nouvel implant intraoculaire accomodatif
DE60236587D1 (de)	2010-07-15	Latexzusammensetzung
FR2803922B1 (fr)	2002-04-05	Lentille ophtalmique
DK1445641T3 (da)	2008-02-04	Okulære linser
EP1364654A4 (en)	2007-10-17	EYE DROP
DK1380585T3 (da)	2005-03-07	Pyrazolopyridinon som mellemprodukt